UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017078
Receipt number R000019450
Scientific Title Evaluation of safety of endoscopic submucosal dissection for gastric neoplasms without discontinuation of thienopyridine derivatives.
Date of disclosure of the study information 2015/04/10
Last modified on 2016/11/29 14:31:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of safety of endoscopic submucosal dissection for gastric neoplasms without discontinuation of thienopyridine derivatives.

Acronym

Gastric ESD on thienopyridines study.

Scientific Title

Evaluation of safety of endoscopic submucosal dissection for gastric neoplasms without discontinuation of thienopyridine derivatives.

Scientific Title:Acronym

Gastric ESD on thienopyridines study.

Region

Japan


Condition

Condition

Gastric neoplasms

Classification by specialty

Gastroenterology Cardiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We aimed to evaluate safety of gastric ESD without discontinuation of thienopyridine derivatives.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Post operative bleeding rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Endoscopic submucosal dissection

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

1) Diagnosed as or suspicious of gastric adenoma/adenocarcinoma (cStageIA).
2) More than six months after last PCI.
3) An oral administration of clopidogrel or prasugrel.
4) A treatment for a single lesion.
5) Older than 19 years and younger than 85 years.
6) Performance status of 0-2.
7) Normal liver, renal, and hematological functions.
8) Follow-up of 60 days after treatment.
9) Written informed consent.

Key exclusion criteria

1) Double registration.
2) A past history of coronary stent embolism.
3) A stent located in left main coronary trunk.
4) A past history of irradiation in upper abdomen.
5) A plan of following treatment for esophageal or duodenal lesions.
6) A recent treatment for upper GI lesions within 28 days before registration.
7) A plan of following treatment for upper GI lesions within 28 days after treatment.
8) A systemic administration of steroids or anticoagulants.
9) An administration of NSAID or other antiplatelets that can be withdrawn before treatment.
10) Pregnancy or bleastfeeding.
11) An active bacterial or fungal infection.
12) A poor control of hypertension.
13) A severe respiratory disease.
14) Other conditions that are judged not suitable.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoshi Ono

Organization

The University of Tokyo

Division name

Department of Gastroenterology

Zip code


Address

7-3-1, Hongo, Bunkyo-ku, Tokyo.

TEL

03-3815-5411

Email

satoshi-tky@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Satoshi Ono

Organization

The University of Tokyo

Division name

Department of Gastroenterology

Zip code


Address

7-3-1, Hongo, Bunkyo-ku, Tokyo.

TEL

03-3815-5411

Homepage URL


Email

satoshi-tky@umin.ac.jp


Sponsor or person

Institute

The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 02 Month 26 Day

Date of IRB


Anticipated trial start date

2015 Year 04 Month 10 Day

Last follow-up date

2016 Year 11 Month 28 Day

Date of closure to data entry

2016 Year 11 Month 28 Day

Date trial data considered complete

2016 Year 11 Month 28 Day

Date analysis concluded

2016 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 04 Month 08 Day

Last modified on

2016 Year 11 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019450


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name